FT α Antibodies

Santa Cruz Biotechnology offers a broad range of FT α Antibodies for research applications in molecular and cellular biology. FT α Antibodies are validated for western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). FT α, or farnesyltransferase alpha, plays a crucial role in the post-translational modification of proteins, influencing cellular processes such as growth, differentiation, and survival. The involvement of FT α in the farnesylation of Ras proteins makes it a significant target in cancer research, as aberrant farnesylation can lead to uncontrolled cell proliferation. Understanding FT α function is essential for developing therapeutic strategies aimed at inhibiting its activity in various diseases. Researchers worldwide utilize FT α monoclonal antibodies to investigate cellular signaling pathways and molecular mechanisms. Advanced research with FT α monoclonal antibodies has revealed new insights into protein modification and cellular regulation. Santa Cruz Biotechnology monoclonal antibodies for FT α continue to support breakthrough discoveries in cancer research and therapeutic development.